National Institute of Neurological Disorders and Stroke; Notice of Meetings, 27738 [06-4455]

Download as PDF 27738 Federal Register / Vol. 71, No. 92 / Friday, May 12, 2006 / Notices where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS.) Dated: May 4, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4454 Filed 5–11–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings sroberts on PROD1PC70 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Council Clinical Trials Subcommittee. Date: May 25, 2006. Open: 8 a.m. to 9 a.m. Agenda: To discuss clinical trials policy. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: 9 a.m. to 9:45 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: John Marler, MD, Associate Director for Clinical Trials, VerDate Aug<31>2005 18:55 May 11, 2006 Jkt 208001 National Institute of Neurological, Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2216, Bethesda, MD 20892, (301) 496–9135, jm137f@nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Council Basic and Preclinical Programs Subcommittee. Date: May 25, 2006. Open: 8 a.m. to 9 a.m. Agenda: To discuss basic and preclinical programs policy. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 8A–28, Bethesda, MD 20892. Closed: 9 a.m. to 9:45 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 8A–28, Bethesda, MD 20892. Contact Person: Robert Baughman, MD, Associate Director for Technology Development, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2137, MSC 9527, Bethesda, MD 20892– 9527, (301) 496–1779. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s Home page: https:// www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). Dated: May 4, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4455 Filed 5–11–06; 8:45 am] available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Commission on Digestive Diseases. Date: June 12, 2006. Time: 9 a.m. to 5 p.m. Agenda: Introduction; review of the stateof-the science; and overview of the Commission’s role and responsibilities. Preregistration is required. Instructions will be available on the Commission’s Web site at https://NCDD.niddk.nih.gov. Place: Hilton Crystal City at National Airport, 2399 Jefferson Davis Hwy, (Route 1), James Room, Arlington, VA 22202. Contact Person: Stephen P. James, MD, Director, Division of Digestive Diseases & Nutrition, National Institute of Diabetes and Digestive, and Kidney Diseases, NIH, 6707 Democracy Blvd., RM 677, Bethesda, MD 20892–5450, 301–594–7680, natlcommdd@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 5, 2006. Anna Snouffer, Acting Director, Office of the Federal Advisory Committee Policy. [FR Doc. 06–4460 Filed 5–11–06; 8:45am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–M National Institute on Aging; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which National Institutes of Health National Institutes of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting of the National Commission on Digestive Diseases. The meeting will be open to the public, with attendance limited to space PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\12MYN1.SGM 12MYN1

Agencies

[Federal Register Volume 71, Number 92 (Friday, May 12, 2006)]
[Notices]
[Page 27738]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4455]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of 
the National Advisory Neurological Disorders and Stroke Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council, Council Clinical Trials Subcommittee.
    Date: May 25, 2006.
    Open: 8 a.m. to 9 a.m.
    Agenda: To discuss clinical trials policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Closed: 9 a.m. to 9:45 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: John Marler, MD, Associate Director for Clinical 
Trials, National Institute of Neurological, Disorders and Stroke, 
National Institutes of Health, 6001 Executive Blvd., Suite 2216, 
Bethesda, MD 20892, (301) 496-9135, jm137f@nih.gov.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council, Council Basic and Preclinical Programs Subcommittee.
    Date: May 25, 2006.
    Open: 8 a.m. to 9 a.m.
    Agenda: To discuss basic and preclinical programs policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 8A-28, Bethesda, MD 20892.
    Closed: 9 a.m. to 9:45 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 8A-28, Bethesda, MD 20892.
    Contact Person: Robert Baughman, MD, Associate Director for 
Technology Development, National Institute of Neurological Disorders 
and Stroke, National Institutes of Health, 6001 Executive Blvd., 
Suite 2137, MSC 9527, Bethesda, MD 20892-9527, (301) 496-1779.

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's Home 
page: https://www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).
    Dated: May 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4455 Filed 5-11-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.